Johnson & Johnson CFO on Q2 earnings, raising guidance, Covid-19 and more

Joseph Wolk, Johnson & Johnson CFO and member of the CNBC Global CFO Council, joins "Squawk Box" to discuss the company's latest quarterly earnings results as well as its decision to raise its yearly guidance and the company's efforts to develop a Covid-19 vaccine and model the trends of the pandemic.
04:39
Thu, Jul 16 20207:20 AM EDT